BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Merged with Streamex
BioSig recently merged with Streamex Exchange Corporation.
Offering Details
Shares of common stock (or pre-funded warrants) are being offered by BioSig.
Use of Proceeds
The net proceeds will be used to purchase gold bullion and for working capital.
- BioSig Technologies is expanding its financial resources through the public offering.
- The completion of the offering is subject to market conditions, with uncertainties regarding its timing and terms.
The public offering marks a strategic move for BioSig Technologies to strengthen its financial position and support its investment policy.